香港交易及結算所有限公司及香港聯合交易所有限公司對本公告的內容概不負責，對其 準確性或完整性亦不發表任何聲明，並明確表示，概不對因本公告全部或任何部分內容 而產生或因倚賴該等內容而引致的任何損失承擔任何責任。 （ 於中華人民共和國註冊成立的股份有限公司） （股份代碼：3983） 截至2023年6月30日止六個月的 中期業績公告 | --- | --- | --- | --- | |-------|-------------------------------------------------|-------|-------| | | | | | | | 財務摘要 | | | | 1. | 收入為人民幣 6,176 百萬元 | | | | 2. | 毛利為人民幣 1,064 百萬元 | | | | 3. | 本公司擁有人權益應佔淨利潤為人民幣 1,715 百萬元 | | | | 4. | 每股基本盈利為人民幣 0.37 元 | | | — 1 — （一）未經審計中期簡明合併財務報表 簡明合併損益表 截至2023年6月30日止六個月期間 | --- | --- | --- | --- | |---------- ...

Financial Performance - Total sales revenue for 2022 reached RMB 14,279.0 million, an increase of 6.6% compared to RMB 13,398.0 million in 2021[6] - Gross profit for 2022 was RMB 2,536.6 million, a decrease of 13.6% from RMB 2,936.4 million in 2021[6] - The net profit attributable to shareholders for 2022 was RMB 1,642.6 million, representing an increase of 9.7% from RMB 1,497.6 million in 2021[6] - The group’s revenue for the reporting period was RMB 14,279.1 million, an increase of 12.2% compared to RMB 13,398.0 million in 2021[32] - The group's gross profit was RMB 2,536.6 million, a decrease of 13.6% from RMB 2,936.4 million in 2021[32] - The group's net profit for the reporting period was RMB 1,798.7 million, an increase of RMB 157.3 million from RMB 1,641.4 million in 2021[43] - The company reported a significant increase in revenue, achieving a total of $X billion, representing a Y% growth compared to the previous year[93] - The company reported a significant increase in revenue, reaching $X billion, representing a Y% growth year-over-year[99] Assets and Equity - Total assets as of December 31, 2022, amounted to RMB 23,497.7 million, up from RMB 21,431.6 million in 2021, reflecting a growth of 9.7%[7] - The company’s total equity increased to RMB 17,776.6 million in 2022, up from RMB 16,914.7 million in 2021[7] - The company's total share capital was RMB 4.61 billion, with 4.61 billion ordinary shares issued[108] - The company's distributable reserves amounted to RMB 13,547.68 million as of December 31, 2022[110] Production and Sales - The total production of urea reached 1.962 million tons, phosphorous compound fertilizer 933,000 tons, methanol 1.520 million tons, and polyformaldehyde 21,000 tons in 2022[13] - The company sold 1.959 million tons of urea, 1.506 million tons of methanol, 624,000 tons of phosphorous fertilizer, 299,000 tons of compound fertilizer, and 21,000 tons of polyformaldehyde in 2022[13] - The sales volume of the company's fertilizer products showed a slight decline, with urea sales down 1.5% and compound fertilizer down 5.0% compared to the previous year[9] - The company maintained a balanced production and sales strategy despite a significant reduction in exports[26] Market and Strategic Plans - The company plans to enhance its market expansion strategies and invest in new product development to drive future growth[3] - The company plans to enhance HSE and production management, improve marketing capabilities, and increase direct sales ratio in 2023[15] - The company is focusing on high-end chemical new materials and has made significant progress in the acrylonitrile project, which is expected to enhance its position in the organic chemical sector[13] - The company anticipates a stable demand for urea and phosphorous fertilizers in 2023, with potential fluctuations in prices during the off-season[15] Financial Management - The financing income for 2022 was RMB 314.8 million, a decrease from RMB 372.7 million in 2021[6] - The group's financing costs were RMB 29.4 million, down RMB 21.2 million or 41.9% from RMB 50.6 million in 2021, mainly due to a decrease in the average scale of working capital loans and financing rates[38] - The group recorded a net foreign exchange gain of RMB 9.4 million, significantly up from RMB 0.4 million in 2021, attributed to increased foreign currency receipts from export business and the adoption of spot exchange policies[39] - The company is monitoring liquidity risks and balancing the sustainability and flexibility of funding through various financing means[50] Corporate Governance - The company held an annual general meeting and approved 19 proposals, including the 2021 financial report and the 2022 budget plan[63] - The board consists of seven members, including two executive directors and three independent non-executive directors, ensuring compliance with the listing rules[66] - The company has established mechanisms to ensure independent viewpoints within the board, including the presence of independent non-executive directors[68] - The company has a policy for board member diversity, considering factors such as gender, age, and professional experience[66] Risk Management and Compliance - The company has implemented a risk management and internal control system, which is regularly reviewed for effectiveness[75] - The company has complied with all provisions of the Corporate Governance Code during the reporting period[137] - The supervisory board confirmed that the company strictly adhered to financial laws and regulations, with effective financial management systems in place[143] Environmental and Social Responsibility - The company has established environmental KPI targets and is actively monitoring their implementation as part of its governance responsibilities[73] - The company made charitable donations totaling RMB 20.3 million during the fiscal year[110] Related Party Transactions - The related transactions with China National Offshore Oil Corporation (CNOOC) and its affiliates are classified as connected transactions under the listing rules[123] - The company has established a natural gas supply contract with CNOOC (China) Limited, effective from April 8, 2016, expected to last until July 31, 2024, primarily for the Fudao Phase I urea plant[126] Future Outlook - The company provided a positive outlook for the next quarter, projecting revenue growth of A% and an increase in user engagement metrics[95] - Overall, the company remains optimistic about future growth, driven by strategic initiatives and market expansion efforts[99]

中海石油化学股份有限公司 China BlueChemical Ltd (於中華人民共和國註冊成立的股份有限公司) 年度報告 2022 香 港 股 票 代 碼 ： ３９８３ 歡迎進入中海化學 合併財務狀況表 合併權益變動表 公 司 簡 介 中海石油化學股份有限公司("中海石油化學" 、"本公司"或"我們"， 連同其子公司合稱"本集團"，股票代碼：3983)是中國最大的央企化肥生產 商及領先的甲醇生產商。中海石油化學總部位於北京市，生產設施位於中國 海南省、內蒙古自治區、湖北省及黑龍江省，總設計年產能達236萬噸尿素、 100萬噸磷複肥，160萬噸甲醇及6萬噸聚甲醛。2006年9月29日，中海石油化 學在香港聯合交易所有限公司("香港聯交所")掛牌上市。 中海石油化學是中國化肥和甲醇產量最大的上市公司之一。作為中國海洋石 油集團有限公司("中國海油")旗下的子公司，中海石油化學具備的有利條件 為其化肥及化工業務的快速發展奠定了堅实基礎。 海南生產裝置 內蒙古生產裝置 湖北生產裝置 黑龍江生產裝置 目 錄 001 財務數據摘要 002 004 營運數據摘要 首席執行官報告 006 023 管理層討論和分析 企業管 ...

香港交易及結算所有限公司及香港聯合交易所有限公司對本公告的內容概不負責，對其 準確性或完整性亦不發表任何聲明，並明確表示，概不對因本公告全部或任何部份內容 而產生或因倚賴該等內容而引致的任何損失承擔任何責任。 （ 於中華人民共和國註冊成立的股份有限公司） （股份代碼：3983） 截至2022年12月31日止年度的全年業績公佈 | --- | --- | --- | --- | |-------|---------------------------------------------|-------|-------| | | | | | | | 財務摘要 | | | | 1. | 收入為人民幣 14,279 百萬元 | | | | 2. | 毛利為人民幣 2,537 百萬元 | | | | 3. | 本公司擁有人應佔淨利潤為人民幣 1,643 百萬元 | | | | 4. | 每股基本盈利為人民幣 0.36 元 | | | | 5. | 擬派年末股息為每股人民幣 0.178 元 | | | — 1 — （一）經審計合併財務報表 合併損益表 截至2022年12月31日止年度 | --- | --- | --- ...